epeleuton (DS102) / Afimmune 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   15 News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epeleuton (DS102) / Afimmune
2020-002911-23: A study to investigate the mechanism of action and safety of Epeleuton capsules in the treatment of patients with type 2 diabetes and diabetic complications

Not yet recruiting
2
25
Europe
DS102 Capsule, DS102, Capsule, hard
Afimmune, Afimmune
Type 2 diabetes and diabetic complications, Type 2 diabetes and diabetic complications, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2020-000065-16: A study to investigate whether Epeleuton capsules are effective as a treatment for high levels of triglycerides in the blood and type 2 diabetes, whether this medicine is safe and what is the best dose.

Not yet recruiting
2
240
Europe
DS102 Capsule, DS102, Capsule, hard
Afimmune Ltd., Afimmune, Afimmune Ltd., Afimmune
Hypertriglyceridemia and Type 2 Diabetes, High triglyceride levels in blood and type 2 diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
NCT05861453: Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients with Sickle Cell Disease

Recruiting
2
30
Canada, US
Epeleuton, DS102 Capsules
Afimmune
Sickle Cell Disease
08/25
09/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epeleuton (DS102) / Afimmune
2020-002911-23: A study to investigate the mechanism of action and safety of Epeleuton capsules in the treatment of patients with type 2 diabetes and diabetic complications

Not yet recruiting
2
25
Europe
DS102 Capsule, DS102, Capsule, hard
Afimmune, Afimmune
Type 2 diabetes and diabetic complications, Type 2 diabetes and diabetic complications, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
2020-000065-16: A study to investigate whether Epeleuton capsules are effective as a treatment for high levels of triglycerides in the blood and type 2 diabetes, whether this medicine is safe and what is the best dose.

Not yet recruiting
2
240
Europe
DS102 Capsule, DS102, Capsule, hard
Afimmune Ltd., Afimmune, Afimmune Ltd., Afimmune
Hypertriglyceridemia and Type 2 Diabetes, High triglyceride levels in blood and type 2 diabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18]
 
 
NCT05861453: Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients with Sickle Cell Disease

Recruiting
2
30
Canada, US
Epeleuton, DS102 Capsules
Afimmune
Sickle Cell Disease
08/25
09/25

Download Options